| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |